Health equality, race and pharmacogenomics
British Journal of Clinical Pharmacology2021Vol. 88(1), pp. 27–33
Citations Over TimeTop 10% of 2021 papers
Abstract
Pharmacogenomics is increasingly moving into mainstream clinical practice. Careful consideration must be paid to inclusion of diverse populations in research, translation and implementation, in the historical and social context of population stratification, to ensure that this leads to improvements in healthcare for all rather than increased health disparities. This review takes a broad and critical approach to the current role of diversity in pharmacogenomics and addresses potential pitfalls in order to raise awareness for prescribers. It also emphasizes evidence gaps and suggests approaches that may minimize negative consequences and promote health equality.
Related Papers
- → Race, Healthcare, and Health Disparities: A Critical Review and Recommendations for Advancing Health Equity(2023)148 cited
- → Z-Codes: An underutilized strategy to identify social determinants of health (SDOH), eliminate health disparities, and achieve health equity(2023)7 cited
- → Health Disparities in Latino Communities(2012)3 cited
- → Disparities in Health and Health Care(2017)1 cited
- → Overview of Minority Health and Health Disparities in the US(2006)